Average weight loss at 68 weeks: Semaglutide (Wegovy): ~15% of total body weight Tirzepatide (Zepbound/Mounjaro): ~2022% Approximately one in three patients loses 20% of body weight
Curr Opin Pharmacol (2017) 33:3440
Prescriptions for patients below BMI 27 are automatically denied unless there's a documented endocrine disorder causing weight gain
When you participate in a program through us, your provider reviews your full medical history, including all current prescriptions like topiramate
visceral fat 0.6 lbs, confirmed via DEXA body-composition scan Takeaway: Biomarker gains are possible, but weight loss was modest
Basically, when you work out, especially during intense strength training, a component called acetyl CoA is produced in a large amount into the muscles, producing lactate and causing lactate buildup